Hot Investor Mandate: New York VC Firm Invests in Novel Oncology Therapeutics, Diagnostics, and Devices, Including Rare Cancers

6 Dec

A New York-based investment firm typically invests up to $6 million per investment with the ability to bring in additional LP side pocket money. The firm invests primarily in the USA but is also open to considering opportunities in Canada.

The firm only invests in oncology companies. Within the oncology field, the firm invests in proprietary technologies in therapeutics, diagnostics and devices, and is open to investing in any form of cancer (including rare cancers), but has a preference for investing in large market opportunities. The firm prefers to invest in companies that have attained proof of concept data in animals and have entered into human clinical trials.

The firm prefer to work with highly qualified, experienced management teams.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: